Antidiabetic agents as potential cytotoxic candidates for cancer therapy
, et
10 juin 2025
À propos de cet article
Catégorie d'article: Research Article
Publié en ligne: 10 juin 2025
Pages: 68 - 89
Reçu: 16 mars 2024
Accepté: 16 août 2024
DOI: https://doi.org/10.2478/fco-2023-0041
Mots clés
© 2024 Raniah I. Alnaser et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Figure 1:
![Difference in glucose metabolism between normal and cancer cells [22].](https://sciendo-parsed.s3.eu-central-1.amazonaws.com/6471cdf2215d2f6c89db169a/j_fco-2023-0041_fig_001.jpg?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Credential=AKIA6AP2G7AKOUXAVR44%2F20250907%2Feu-central-1%2Fs3%2Faws4_request&X-Amz-Date=20250907T091058Z&X-Amz-Expires=3600&X-Amz-Signature=6e8e4386bf921bb66aa3f971ec23428272f681662028e8ffbd53056a64a5dc22&X-Amz-SignedHeaders=host&x-amz-checksum-mode=ENABLED&x-id=GetObject)
Figure 2:
Summary of the cytotoxic effects of some antidiabetic drugs_
| Metformin | Breast cancer | [ |
|
| Colorectal cancer | [ |
||
| Endometrial cancer | [ |
||
| Ovarian cancer | [ |
||
| Skin cancer | [ |
||
| Thyroid cancer | [ |
||
| Head and neck cancer | [ |
||
| Pancreatic cancer | [ |
||
| Lung cancer | [ |
||
| Glibenclamide | Gastric cancer | [ |
|
| Breast cancer | [ |
||
| Hepatocellular carcinoma | [ |
||
| Colon cancer | [ |
||
| Glioblastoma | [ |
||
| Rosiglitazone | Neuroblastoma | [ |
|
| Vildagliptin and sitagliptin | Colorectal cancer | [ |
|
| Vildagliptin, sitagliptin, and gemigliptin | Thyroid cancer | [ |
|
| Vildagliptin, sitagliptin, and sitagliptin | Chronic myeloid leukemia | [ |
|
| Vildagliptin | Lung cancer | [ |
|
| Sitagliptin | Gastric cancer | [ |
|
| Breast cancer | [ |
||
| Endometrial cancer | [ |
||
| Cervical carcinoma | [ |
||
| Glioblastoma cancer in the brain | [ |
||
| Exenatide-4 | Hepatocellular carcinoma | [ |
|
| Breast cancer | [ |
||
| Prostate cancer | [ |
||
| Endometrial cancer | [ |
||
| Liraglutide | Endometrial cancer | [ |
|
| Dapagliflozin | Pancreatic carcinoma | [ |
|
| Renal carcinoma (in humans) | [ |
||
| Human colon carcinoma | [ |
||
| Canagliflozin | Pancreatic cancer and early-stage lung cancer | [ |
|
| Hepatocellular carcinoma (in humans) | [ |
||
| Lung cancer | [ |
||
| Breast cancer | [ |
||
| Prostate cancer | [ |
||
| Thyroid cancer | [ |
||
| Ipragliflozin | Breast carcinoma | [ |
|